Amos Levi, Matthias Linder, Moritz Seiffert, Guy Witberg, Thomas Pilgrim, Daijiro Tomii, Yeela Tamlor Barkan, Nicolas M Van Mieghem, Rik Adrichem, Pablo Codner, David Hildick-Smith, Sandeep Arunothayaraj, Leor Perl, Ariel Finkelstein, Itamar Loewenstein, Ole De Backer, Rani Barnea, Giuseppe Tarantini, Luca Nai Fovino, Hana Vaknin-Assa, Darren Mylotte, Max Wagener, John G Webb, Mariama Akodad, Antonio Colombo, Antonio Mangieri, Azeem Latib, Faraj Kargoli, Francesco Giannini, Alfonso Ielasi, Lars Søndergaard, Itay Aviram, Tsahi T Lerman, Mark Kheifets, Eitan Auriel, Ran Kornowski
BACKGROUND: Acute ischemic stroke remains a serious complication of transcatheter aortic valve replacement (TAVR). Cerebral embolic protection devices (CEPD) were developed to mitigate the risk of acute ischemic stroke complicating TAVR (AISCT). However, the existing body of evidence does not clearly support CEPD efficacy in AISCT prevention. OBJECTIVES: In a cohort of patients with AISCT, we aimed to compare the characteristics and outcomes of patients who have had unprotected TAVR (CEPD-) vs CEPD-protected TAVR (CEPD+)...
March 11, 2024: JACC. Cardiovascular Interventions